Dual Mechanisms of HNO Generation by a Nitroxyl Prodrug of the Diazeniumdiolate (NONOate) Class
Authors:
- Debra J. SalmonDSDebra J. Salmon
- Sonia DonzelliSDSonia Donzelli
- Azadeh WahabAWAzadeh Wahab
- John R. KloseJKJohn R. Klose
- Michael L. CitroMCMichael L. Citro
- Joseph E. SaavedraJSJoseph E. Saavedra
- David A. WinkDWDavid A. Wink
- Katrina M. MirandaKMKatrina M. Miranda
- Larry K. KeeferLKLarry K. Keefer
Open Access
- 29 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 132 (46) , 16526-16532
Abstract
Here we describe a novel caged form of the highly reactive bioeffector molecule, nitroxyl (HNO). Reacting the labile nitric oxide (NO)- and HNO-generating salt of structure iPrHN−N(O)═NO−Na+ (1, IPA/NO) with BrCH2OAc produced a stable derivative of structure iPrHN-N(O)═NO−CH2OAc (2, AcOM-IPA/NO), which hydrolyzed an order of magnitude more slowly than 1 at pH 7.4 and 37 °C. Hydrolysis of 2 to generate HNO proceeded by at least two mechanisms. In the presence of esterase, straightforward dissociation to acetate, formaldehyde, and 1 was the dominant path. In the absence of enzyme, free 1 was not observed as an intermediate and the ratio of NO to HNO among the products approached zero. To account for this surprising result, we propose a mechanism in which base-induced removal of the N−H proton of 2 leads to acetyl group migration from oxygen to the neighboring nitrogen, followed by cleavage of the resulting rearrangement product to isopropanediazoate ion and the known HNO precursor, CH3−C(O)−NO. The trappable yield of HNO from 2 was significantly enhanced over 1 at physiological pH, in part because the slower rate of hydrolysis for 2 generated a correspondingly lower steady-state concentration of HNO, thus, minimizing self-consumption and enhancing trapping by biological targets such as metmyoglobin and glutathione. Consistent with the chemical trapping efficiency data, micromolar concentrations of prodrug 2 displayed significantly more potent sarcomere shortening effects relative to 1 on ventricular myocytes isolated from wild-type mouse hearts, suggesting that 2 may be a promising lead compound for the development of heart failure therapies.Keywords
This publication has 47 references indexed in Scilit:
- Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674Circulation Research, 2009
- Nitroxyl Anion Donor, Angeli’s Salt, Does Not Develop Tolerance in Rat Isolated AortaeHypertension, 2007
- Antioxidant actions of nitroxyl (HNO)Free Radical Biology and Medicine, 2007
- The pharmacology of nitroxyl (HNO) and its therapeutic potential: Not just the janus face of NO11This review is dedicated to the career of Prof. Herbert T. Nagasawa, a pioneer in the field of HNO chemistry, biochemistry and pharmacology.Pharmacology & Therapeutics, 2007
- Chemistry of the Diazeniumdiolates: Z ⇌ E IsomerismJournal of the American Chemical Society, 2005
- Mechanisms of Reductive Nitrosylation in Iron and Copper Models Relevant to Biological SystemsChemical Reviews, 2005
- Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenaseJournal of Medicinal Chemistry, 1992
- N,O-Diacylated-N-hydroxyarylsulfonamides: Nitroxyl precursors with potent smooth muscle relaxant propertiesBiochemical and Biophysical Research Communications, 1992
- On the Role of the Nitroxyl Molecule in the Reaction of Hydrogen Atoms with Nitric OxideJournal of the American Chemical Society, 1965
- The Alleged Role of Nitroxyl in Certain Reactions of Aldehydes and Alkyl Halides1Journal of the American Chemical Society, 1960